TherapeuticsMD (TXMD) Leases (2019 - 2025)
Historic Leases for TherapeuticsMD (TXMD) over the last 7 years, with Q3 2025 value amounting to $5.5 million.
- TherapeuticsMD's Leases fell 1248.81% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 1248.81%. This contributed to the annual value of $6.1 million for FY2024, which is 1121.78% down from last year.
- According to the latest figures from Q3 2025, TherapeuticsMD's Leases is $5.5 million, which was down 1248.81% from $5.7 million recorded in Q2 2025.
- In the past 5 years, TherapeuticsMD's Leases ranged from a high of $9.2 million in Q1 2021 and a low of $5.5 million during Q3 2025
- Moreover, its 5-year median value for Leases was $7.2 million (2023), whereas its average is $7.2 million.
- The largest annual percentage gain for TherapeuticsMD's Leases in the last 5 years was 565.91% (2021), contrasted with its biggest fall of 1588.58% (2021).
- Over the past 5 years, TherapeuticsMD's Leases (Quarter) stood at $8.2 million in 2021, then decreased by 7.94% to $7.6 million in 2022, then fell by 9.33% to $6.9 million in 2023, then fell by 11.22% to $6.1 million in 2024, then dropped by 9.62% to $5.5 million in 2025.
- Its Leases was $5.5 million in Q3 2025, compared to $5.7 million in Q2 2025 and $5.9 million in Q1 2025.